Drug Delivery in Oncology and Immunotherapy

Oncology and immunotherapy demand precision-targeted drug delivery systems to maximize therapeutic index and minimize toxicity. Nanocarriers, antibody-drug conjugates, and polymer-drug conjugates are at the forefront of innovation. These platforms enable site-specific delivery, controlled release, and reduced off-target effects. Immunotherapeutic delivery methods are being refined for vaccines, cytokines, and immune checkpoint inhibitors. Personalized formulations and tumor microenvironment-targeted systems are reshaping cancer treatment by enhancing efficacy and patient survival while reducing adverse effects.

    Related Conference of Drug Delivery in Oncology and Immunotherapy

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Drug Delivery in Oncology and Immunotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in